Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies David Nanchen, MD, Arnaud Chiolero, MD,

Slides:

Advertisements

Similar presentations

The “no reflow” phenomenon following acute myocardial infarction: Mechanisms and treatment options Sanjiv Kaul, MD Journal of Cardiology Volume 64, Issue.

Advertisements

Low-Dose Aspirin in Patients with Stable Cardiovascular Disease: A Meta-analysis Jeffrey S. Berger, MD, MS, David L. Brown, MD, Richard C. Becker, MD The.

Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.

Determinants of Cardiorespiratory Fitness in Men Aged 42 to 60 Years With and Without Cardiovascular Disease Jari Antero Laukkanen, MD, PhD, David Laaksonen,

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Fredrik Karlsson, MD, Angelo Modica, MD, Thomas Mooe, MD, PhD

The Epidemic of the 20th Century: Coronary Heart Disease

Trends in Outcomes of Revascularization for Left Main Coronary Disease or Three- Vessel Disease With the Routine Incorporation of Fractional Flow Reserve.

Impact of Co-morbidity on the Risk of First-Time Myocardial Infarction, Stroke, or Death After Single-Photon Emission Computed Tomography Myocardial Perfusion.

Frequency of Left Ventricular Thrombus in Patients With Anterior Wall Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention and.

Paul D. Stein, MD, Fadi Matta, MD, Mary J. Hughes, DO

From: Pharmacologic Therapy for Type 2 Diabetes Mellitus

Frequency of Percutaneous Coronary Interventions at Facilities Without On-Site Cardiac Surgical Backup—A Report from the American College of Cardiology–National.

Community-Based Mind–Body Meditative Tai Chi Program and Its Effects on Improvement of Blood Pressure, Weight, Renal Function, Serum Lipoprotein, and.

Does Diabetes Mellitus Abolish the Beneficial Effect of Primary Coronary Angioplasty on Long-term Risk of Reinfarction After Acute ST-Segment Elevation.

Meta-Analysis of Dietary Glycemic Load and Glycemic Index in Relation to Risk of Coronary Heart Disease Jia-Yi Dong, BSc, Yong-Hong Zhang, MD, PhD, Peiyu.

Comparison of Bare-Metal Stents and Drug-Eluting Stents in Coronary Ostial Lesions (from the National Heart, Lung, and Blood Institute Dynamic Registry)

Contribution of Three-Dimensional Transesophageal Echocardiography to Diagnosis and Management of Thrombosis of a St. Jude Mechanical Prosthesis in the.

Aspirin Use Among U.S. Adults

Alfred A. Bartolucci, PhD, Michal Tendera, MD, George Howard, DrPH

Usefulness of Matrix Metalloproteinase-9 Plasma Levels to Identify Patients With Preserved Left Ventricular Systolic Function After Acute Myocardial Infarction.

Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction.

Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction

Alexander A. Leung, MD, MPH, Finlay A. McAlister, MD, MSc, Samuel R. G

Total Antioxidant Capacity from Diet and Risk of Myocardial Infarction: A Prospective Cohort of Women Susanne Rautiainen, MSc, Emily B. Levitan, DrPh,

Recurrent infarction causes the most deaths following myocardial infarction with left ventricular dysfunction Stein Ørn, MD, John G.F. Cleland, MD, Matti.

Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction: The View of the Preventive Cardiologist Nishant P. Shah, MD, Miguel Cainzos-Achirica,

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Martin W. Schoen, MD, MPH, Joanne Salas, MPH, Jeffrey F

Overweight and obesity as risk factors for atrial fibrillation or flutter: The Danish Diet, Cancer, and Health Study Lars Frost, MD, PhD, Lone Juul Hune,

Impact of Hyponatremia Correction on the Risk for 30-Day Readmission and Death in Patients with Congestive Heart Failure Jacques D. Donzé, MD, MSc, Patrick.

Trends in Stroke Rates, Risk, and Outcomes in the United States, 1988 to 2008 Margaret C. Fang, MD, MPH, Marcelo Coca Perraillon, MA, Kaushik Ghosh, PhD,

Sayed H. Naderi, BMedSci, Jonathan P. Bestwick, MSc, David S. Wald, MD

Wandering Acute Myocardial Infarction

Todd A. Lee, PharmD, PhD, Brian Bartle, MPH, Kevin B. Weiss, MD, MPH

Net Clinical Benefit of Non-vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Phase III Atrial Fibrillation Trials Giulia Renda, MD, PhD, Marta.

Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease Nina Raju, MD, MsC, Magdalena Sobieraj-Teague, MBBS, Jack Hirsh, MD,

Epidemiology of Myelodysplastic Syndromes

Trend in Mortality after Stroke with Atrial Fibrillation

The Epidemic of the 20th Century: Coronary Heart Disease

Robert Goulden, MBBS, MSc, MPhil, MA The American Journal of Medicine

Adherence to Secondary Prevention Medications and Four-year Outcomes in Outpatients with Atherosclerosis Dharam J. Kumbhani, MD, SM, MRCP, Ph. Gabriel.

Quality of Care for Myocardial Infarction at Academic and Nonacademic Hospitals Loic Belle, MD, José Labarère, MD, Magali Fourny, MSc, Elodie Drouet,

When Guidelines Cause Hypertension

Subclinical Hypothyroidism and the Risk of Coronary Heart Disease: A Meta-Analysis Nicolas Rodondi, MD, MAS, Drahomir Aujesky, MD, MS, Eric Vittinghoff,

Catherine Buettner, MD, MPH, Matthew J. Rippberger, MA, Julie K

Blood Pressure Usually Considered Normal Is Associated with an Elevated Risk of Cardiovascular Disease Abhijit V. Kshirsagar, MD, MPH, Myra Carpenter,

Repeated Hemoglobin A1C Ordering in the VA Health System

The Potential Effects of Implementing the 2013 ACC/AHA Cholesterol Guidelines on the Use of Statins in a Large Health Maintenance Organization in Israel

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

David M Nathan, MD, James Meigs, MPH, Daniel E Singer, MD The Lancet

On Statin Treatment to Prevent Sepsis in Dialysis Patients

Mohammed Al-Omran, MD, MSc, Muhammad M

Cardiovascular Risk Assessment Among Potential Kidney Transplant Candidates: Approaches and Controversies Krista L. Lentine, MD, MS, Frank P. Hurst,

A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico

Eleanor Roosevelt's Last Days: A Bioethical Case Study

Yader Sandoval, MD, Stephen W. Smith, MD, Sara A

Shannon M. Dunlay, MD, MS, Quinn R. Pack, MD, Randal J

Prevalence and Risk Factors for Erectile Dysfunction in the US

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Effect of Folic Acid, with or without Other B Vitamins, on Cognitive Decline: Meta- Analysis of Randomized Trials David S. Wald, MA, MRCP, MD, Anuradhani.

Peter A. McCullough, MD, MPH, Christopher T. Chan, MD, Eric D

Risk of Falls and Major Bleeds in Patients on Oral Anticoagulation Therapy Jacques Donzé, MD, MSc, Carole Clair, MSc, MD, Balthasar Hug, MD, MBA, MPH,

Siva Raja, MD, PhD, Jay J. Idrees, MD, Eugene H

Discussion The Journal of Thoracic and Cardiovascular Surgery

Higher Cardiovascular Disease Prevalence and Mortality among Younger Blacks Compared to Whites Stacey Jolly, MD, MS, Eric Vittinghoff, PhD, Arpita Chattopadhyay,

Maral Ouzounian, MD, PhD, Amine Mazine, MD, MSc, Tirone E. David, MD

Dialysis Research and N-of-1 Trials: Made for Each Other?

Falls in Older Adults: Risk Assessment, Management and Prevention

Secular trends in cardiovascular disease mortality, incidence, and case fatality rates in adults in the United States Ahmet Ergin, MD, PhD, MPH, Paul.

Presentation transcript:

Cardiovascular Risk Estimation and Eligibility for Statins in Primary Prevention Comparing Different Strategies David Nanchen, MD, Arnaud Chiolero, MD, MSc, Jacques Cornuz, MD, MPH, Pedro-Manuel Marques-Vidal, MD, PhD, Mathieu Firmann, MD, Vincent Mooser, MD, Fred Paccaud, MD, MSc, Gérard Waeber, MD, Peter Vollenweider, MD, Nicolas Rodondi, MD, MAS American Journal of Cardiology Volume 103, Issue 8, Pages 1089-1095 (April 2009) DOI: 10.1016/j.amjcard.2008.12.042 Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 1 Percentages of men (left) and women (right) at estimated high risk according to FRS/ATP-III (diamonds), PROCAM/IAS (triangles), SCORE/ESC (squares and solid lines), and SCORE/ESC with extrapolation (squares and dashed lines). American Journal of Cardiology 2009 103, 1089-1095DOI: (10.1016/j.amjcard.2008.12.042) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 2 Percentages of participants currently under statin treatment or eligible according to FRS/ATP-III, PROCAM/IAS, and SCORE/ESC with/without extrapolation. American Journal of Cardiology 2009 103, 1089-1095DOI: (10.1016/j.amjcard.2008.12.042) Copyright © 2009 Elsevier Inc. Terms and Conditions

Figure 3 (A) Estimated number of CHD deaths potentially adverted and number needed to treat (NNT) to avoid 1 CHD death over 10 years according to FRS/ATP-III (diamonds), PROCAM/IAS (triangles), SCORE/ESC (squares and solid lines), and SCORE/ESC with extrapolation (squares and dashed lines) for 10-year statin treatment, based on full compliance and extrapolated to Swiss men (top) and women (bottom) without CVD 35 to 75 years of age. (B) Estimated number of myocardial infarctions potentially adverted and NNT to avoid 1 myocardial infarction in a 10-year period with full compliance to the different guidelines for 10-year statin treatment, extrapolated to Swiss men without cardiovascular disease 35 to 75 years of age. American Journal of Cardiology 2009 103, 1089-1095DOI: (10.1016/j.amjcard.2008.12.042) Copyright © 2009 Elsevier Inc. Terms and Conditions